Valley National Advisers’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.2K Sell
232
-6
-3% -$1.18K 0.01% 416
2026
Q1
$46K Sell
238
-207
-47% -$40.2K 0.01% 411
2025
Q4
$77K Sell
445
-77
-15% -$14K 0.01% 348
2025
Q3
$99K Sell
522
-232
-31% -$41.2K 0.02% 302
2025
Q2
$135K Sell
754
-130
-15% -$22.6K 0.02% 274
2025
Q1
$149K Sell
884
-361
-29% -$59.3K 0.03% 254
2024
Q4
$187K Sell
1,245
-1,020
-45% -$159K 0.03% 230
2024
Q3
$351K Sell
2,265
-1,270
-36% -$190K 0.06% 190
2024
Q2
$482K Sell
3,535
-187
-5% -$25.6K 0.07% 161
2024
Q1
$494K Sell
3,722
-418
-10% -$54.2K 0.07% 165
2023
Q4
$569K Sell
4,140
-175
-4% -$23K 0.09% 148
2023
Q3
$526K Sell
4,315
-609
-12% -$81.1K 0.09% 152
2023
Q2
$693K Sell
4,924
-91
-2% -$12.5K 0.12% 136
2023
Q1
$735K Buy
5,015
+106
+2% +$15.2K 0.13% 133
2022
Q4
$750K Sell
4,909
-81
-2% -$11.6K 0.13% 128
2022
Q3
$647K Sell
4,990
-136
-3% -$17.9K 0.13% 133
2022
Q2
$696K Sell
5,126
-3
-0.1% -$409 0.15% 114
2022
Q1
$702K Buy
+5,129
New +$715K 0.13% 144
2019
Q1
Sell
-35
Closed -$3K 756
2018
Q4
$3K Buy
+35
New +$3.28K ﹤0.01% 582

Other funds holding DGX

Valley National Advisers's DGX Position: Q2 2026 in Review

Valley National Advisers reduced its Quest Diagnostics (DGX) stake by 2.5% in Q2 2026, selling an estimated $1.18K and leaving 232 shares worth $49.2K. The position accounts for 0.01% of the portfolio, ranked #416.

Valley National Advisers first reported a position in DGX in Q4 2018 and has held it in 19 quarters since. The position peaked at $750K in Q4 2022. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Valley National Advisers held 232 shares of Quest Diagnostics worth $49.2K as of Q2 2026.
  • Valley National Advisers sold 6 Quest Diagnostics shares in Q2 2026, an estimated $1.18K.
  • Quest Diagnostics made up 0.01% of Valley National Advisers's portfolio in Q2 2026, its #416 holding.
  • Valley National Advisers first reported a position in Quest Diagnostics in Q4 2018 and has held it in 19 quarters since.
  • Valley National Advisers's Quest Diagnostics position peaked at $750K in Q4 2022.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.